Core Viewpoint - A class action lawsuit has been filed against Varonis Systems, Inc. on behalf of investors who acquired its securities during the specified Class Period, highlighting concerns over undisclosed issues related to customer renewals and revenue guidance [1][3]. Company Overview - Varonis Systems, Inc. is a global security company based in Miami, Florida, specializing in software products that utilize AI technologies to detect advanced security threats [2]. Financial Performance and Issues - On October 28, 2025, Varonis disclosed a significant miss in annual recurring revenue (ARR) and reduced its full fiscal year 2025 guidance, attributing this to weaker than expected customer renewals and conversions in its subscription business [3]. - The company also announced the end-of-life for its self-hosted solution and a 5% reduction in headcount during the same announcement [3]. Stock Market Reaction - Following the announcement of poor financial results, Varonis' stock price plummeted from $63.00 per share to $32.34 per share on October 29, 2025, marking a decline of $30.66 per share, or over 48% in a single day [4].

Core Viewpoint - The PayPal class action lawsuit alleges that the company and certain executives misled investors regarding the company's revenue outlook and growth potential during the Class Period, leading to significant financial losses for shareholders [3][4]. Group 1: Lawsuit Details - The class action lawsuit is titled Goodman v. PayPal Holdings, Inc., and it involves purchasers of PayPal common stock from February 25, 2025, to February 2, 2026, with a deadline of April 20, 2026, for seeking lead plaintiff status [1]. - The lawsuit claims that PayPal's management created a false impression of reliable revenue projections while downplaying risks associated with seasonality and macroeconomic factors [3]. - On February 3, 2026, PayPal reported disappointing fourth-quarter and full-year 2025 results, including a decline in Branded Checkout performance and the withdrawal of previously set 2027 financial targets, which led to a stock price drop of over 20% [4]. Group 2: Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased PayPal common stock during the Class Period to seek appointment as lead plaintiff, representing the interests of the class [5]. - A lead plaintiff is typically the investor with the greatest financial interest in the case and can select a law firm to represent the class [5]. Group 3: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 alone [6]. - The firm has a strong track record, recovering $8.4 billion for investors over the past five years, making it one of the largest plaintiffs' firms globally [6].

Core Points - The CoreWeave class action lawsuit has been initiated against CoreWeave, Inc. and certain executives for alleged violations of the Securities Exchange Act of 1934 during the Class Period from March 28, 2025, to December 15, 2025 [1][3] - CoreWeave is positioned as an AI cloud computing company and had announced a significant deal worth up to $11.9 billion with OpenAI shortly before its IPO [2][3] - The lawsuit claims that CoreWeave overstated its ability to meet customer demand and failed to disclose risks associated with reliance on a single third-party data center supplier, which could negatively impact revenue [3][4] Allegations and Events - On October 30, 2025, Core Scientific announced it did not receive enough shareholder votes to approve its merger with CoreWeave, leading to a more than 6% drop in CoreWeave's share price [4] - On November 10, 2025, CoreWeave lowered its revenue guidance for 2025 due to delays from a third-party data center developer, resulting in a subsequent 16% drop in share price [5] - A December 15, 2025 article from The Wall Street Journal revealed that delays in data center delivery were more severe than previously acknowledged, causing an additional 3.4% decline in share price [6] Legal Process - Investors who purchased CoreWeave securities during the Class Period can seek appointment as lead plaintiff in the class action lawsuit, representing the interests of all class members [7] - The lead plaintiff can select a law firm to litigate the case, and participation as lead plaintiff is not required to share in any potential recovery [8] About the Law Firm - Robbins Geller Rudman & Dowd LLP is a leading firm in complex class action litigation, having recovered over $916 million for investors in 2025 alone, and $8.4 billion over the past five years [9]

Core Viewpoint - Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Duolingo, Inc. following a significant decline in its stock price after the company announced disappointing financial results and guidance [1][3]. Group 1: Investigation Details - The investigation focuses on whether Duolingo's executive officers complied with federal securities laws, particularly in light of the company's recent disclosures [4]. - Duolingo's stock fell by over 30% in pre-market trading on February 27, 2026, after the announcement of slower bookings growth and reduced profitability expectations [3]. Group 2: Company Background - Duolingo announced its financial results for the fourth quarter and full fiscal year ended December 31, 2025, on February 26, 2026 [3]. - The company is facing scrutiny from investors due to the significant losses incurred following its financial disclosures [2][4]. Group 3: Law Firm Background - Johnson Fistel, PLLP is a nationally recognized shareholder-rights law firm that represents individual and institutional investors in securities class action lawsuits [5]. - The firm has a strong track record, having recovered approximately $90,725,000 for clients in previous cases, and has been recognized as a top plaintiffs' securities law firm multiple times [6].

Core Viewpoint - Hub Group Inc. is under investigation for potential violations of federal securities laws, specifically regarding misrepresentation of financial data related to transportation costs and accounts payable for the first nine months of 2025 [1][2]. Group 1: Investigation Details - Bleichmar Fonti & Auld LLP is leading the investigation into Hub Group for possible misrepresentation of its purchased transportation costs and accounts payable [2]. - The investigation follows Hub Group's announcement of a delay in releasing its fourth quarter and full year 2025 financial results, along with a restatement of its financial statements for the first three quarters of 2025 due to an error [3]. Group 2: Stock Market Reaction - Following the announcement of the financial restatement, Hub Group's stock price dropped over 24% during trading on February 6, 2026 [4].

Core Viewpoint - The Navan class action lawsuit alleges that Navan, Inc. and its executives misled investors regarding the company's financial health and future expenses following its IPO on October 31, 2025, leading to significant stock price declines [1][3][4]. Group 1: IPO Details - Navan conducted its IPO on October 31, 2025, issuing nearly 37 million shares at an offering price of $25.00 per share [2]. - The lawsuit claims that the offering documents were materially false and/or misleading, particularly regarding future sales and marketing expenses [3]. Group 2: Financial Performance and Stock Impact - On December 15, 2025, Navan reported a 39% increase in sales and marketing expenses, rising to nearly $95 million from $68.5 million in the previous quarter [4]. - Following the earnings report, Navan's stock price fell nearly 12%, reflecting investor concerns over the increased expenses [4]. - By the time the lawsuit commenced, Navan's stock had traded as low as $9.20 per share, representing a nearly 63% decline from the IPO price [5]. Group 3: Legal Process and Representation - The Private Securities Litigation Reform Act of 1995 allows investors who purchased Navan stock during the IPO to seek appointment as lead plaintiff in the class action lawsuit [6]. - The lead plaintiff represents the interests of all class members and can select a law firm of their choice for litigation [6]. Group 4: Law Firm Background - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 alone [7]. - The firm has a strong track record, recovering $8.4 billion for investors over the past five years, including the largest securities class action recovery in history [7].

Core Viewpoint - A class action lawsuit has been filed against Plug Power Inc. and certain senior executives for securities fraud following significant stock drops attributed to potential violations of federal securities laws [1][4]. Group 1: Lawsuit Details - Investors have until April 3, 2026, to request to lead the case, which is pending in the U.S. District Court for the Northern District of New York [4][10]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of Plug Power investors [4]. Group 2: Allegations Against Plug Power - Plug Power is accused of materially overstating the likelihood of receiving a $1.66 billion loan guarantee from the U.S. Department of Energy, which was intended to finance the construction of hydrogen production facilities [5]. - The company provides hydrogen fuel cell solutions and develops infrastructure for hydrogen production [5]. Group 3: Stock Performance and Impact - Following the announcement of the abrupt departure of CEO Andrew Marsh and President Sanjay Shrestha on October 7, 2025, Plug Power's stock dropped by $0.26 per share, or 6.3% [6]. - On November 10, 2025, the suspension of activities under the DOE loan program led to a further stock decline of $0.09 per share, or 3.4% [7]. - A report on November 13, 2025, confirming the suspension of plans to construct hydrogen facilities resulted in a significant stock drop of $0.48 per share, or 17.6% [8].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][4]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [4]. - Investors have until March 9, 2026, to request to be appointed to lead the case [4][9]. - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Ardent Health securities [4]. Group 2: Allegations Against Ardent Health - The lawsuit alleges that Ardent Health misrepresented its accounts receivable collection practices, claiming to rely on "detailed reviews of historical collections," while actually using a 180-day cliff method for reserving uncollectable accounts [5]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses [5]. Group 3: Stock Performance Impact - On November 12, 2025, Ardent Health disclosed a $43 million revenue decrease for the quarter and increased its professional liability reserves by $54 million, leading to a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 on November 13, 2025 [6][9].

Core Viewpoint - Ultragenyx Pharmaceutical Inc. is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company misled investors regarding the efficacy of its drug setrusumab for treating Osteogenesis Imperfecta [1][1][1] Summary by Relevant Sections Class Action Details - Investors who purchased Ultragenyx common stock between August 3, 2023, and December 26, 2025, can seek to be lead plaintiffs in the class action lawsuit, which is titled Bailey v. Ultragenyx Pharmaceutical Inc. [1][1] - The lawsuit alleges that Ultragenyx and its executives made false statements about the reliability of data from the Phase III Orbit study, which was intended to show the drug's effectiveness [1][1] Allegations Against Ultragenyx - The lawsuit claims that Ultragenyx created a misleading impression of having reliable information regarding the effects of setrusumab while downplaying the risks associated with the Phase III Orbit study [1][1] - It is alleged that the company failed to disclose that the Phase II results lacked a placebo control group, which could have influenced the perceived effectiveness of the treatment [1][1] Stock Price Impact - Following the announcement on July 9, 2025, that the Phase III Orbit study did not achieve statistical significance, Ultragenyx's stock price fell by more than 25% [1][1] - On December 29, 2025, after revealing that both the Phase III Orbit and Cosmic studies failed to meet primary endpoints, the stock price dropped by over 42% [1][1] Legal Process for Lead Plaintiffs - The Private Securities Litigation Reform Act of 1995 allows any investor who acquired Ultragenyx common stock during the class period to seek appointment as lead plaintiff, representing the interests of all class members [1][1] - The lead plaintiff can choose a law firm to litigate the case, and participation as lead plaintiff does not affect an investor's ability to share in any potential recovery [1][1] About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a prominent law firm specializing in securities fraud and shareholder rights litigation, having recovered over $916 million for investors in 2025 alone [1][1] - The firm has a strong track record, recovering $8.4 billion for investors over the past five years, making it one of the largest plaintiffs' firms globally [1][1]

Core Viewpoint - Richtech Robotics Inc. is facing a class action lawsuit for allegedly misleading investors about its relationship with Microsoft, which has resulted in a significant drop in its stock price [3][4]. Group 1: Class Action Lawsuit Details - The class action lawsuit, titled Diez v. Richtech Robotics Inc., allows purchasers of Richtech Robotics securities from January 27, 2026, to January 29, 2026, to seek lead plaintiff status by April 3, 2026 [1]. - The lawsuit alleges that Richtech Robotics falsely claimed a commercial relationship with Microsoft during the class period [3]. - Following the publication of an article by Hunterbrook Media on January 29, 2026, which denied any partnership with Microsoft, Richtech Robotics' Class B stock price fell over 29% within two trading days [4]. Group 2: Lead Plaintiff Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Richtech Robotics securities during the class period to seek lead plaintiff status, representing the interests of the class [5]. - The lead plaintiff is typically the investor with the greatest financial interest and must be adequate and typical of the class [5]. Group 3: Company Background - Richtech Robotics develops and sells robotic solutions for automation in the service industry [2].